<DOC>
	<DOCNO>NCT00904800</DOCNO>
	<brief_summary>This phase I study evaluate safety tolerability repeat dos AZD0837 .</brief_summary>
	<brief_title>AZD0837 Extended Release ( ER ) Japan Study</brief_title>
	<detailed_description />
	<criteria>Healthy male Japanese subject age 20 45 year inclusive Acute illness ( include ongoing history liver disease ) , trauma surgical procedure within two week Visit 1 pre first dose Visit 2 Intake another investigational drug within 4 month Visit 1 pre first dose Visit 2 Blood donation and/or sample excess 200 mL whole blood within precede 4 week , 400 mL whole blood within precede 12 week and/or 1200 mL whole blood within precede 12 month , Visit 1 pre first dose Visit 2</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Phase I</keyword>
	<keyword>Healthy volunteer</keyword>
</DOC>